Jonathan Chee (J Chee)

ResearcherID Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Venues

Oncoimmunology

Clinical & translational immunology

Proceedings of the National Academy of Sciences of the United States of America

Scientific reports

Telethon Kids Institute

University of Melbourne (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Telethon Kids Institute

Australia

Visiting Postdoc :: Cancer Immunology

Education History

University of Melbourne

Australia

PHD

Publications

Joel Kidman, Rachael M Zemek, John-William Sidhom, Debora Correa, Nicola Principe, Fezaan Sheikh, Vanessa S Fear, Catherine A Forbes, Abha Chopra, Louis Boon, Ayham Zaitouny, Emma de Jong, Robert A Holt, Matt Jones, Michael J Millward, Timo Lassmann, Alistair R R Forrest, Anna K Nowak, Mark Watson, Richard A Lake, W Joost Lesterhuis, Jonathan Chee
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes. Oncoimmunology 13 (1) (2024)
Tingting Ge, Amber-Lee Phung, Gaurang Jhala, Prerak Trivedi, Nicola Principe, David J De George, Evan G Pappas, Sara Litwak, Laura Sanz-Villanueva, Tara Catterall, Stacey Fynch, Louis Boon, Thomas W H Kay, Jonathan Chee, Balasubramanian Krishnamurthy, Helen E Thomas
Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitor. Clinical & translational immunology 11 (11) (2022)
Shamin Li, Yannick Simoni, Summer Zhuang, Austin M Gabel, Shaokang Ma, Jonathan Chee, Laura V Islas, Anthony Cessna, Jenette Creaney, Robert K Bradley, Alec James Redwood, Bruce W S Robinson, Evan William Newell
Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies. Proceedings of the National Academy of Sciences of the United States of America 118 (30) (2021)
Ben Wylie, Jonathan Chee, Catherine A Forbes, Mitchell Booth, Shane R Stone, Anthony Buzzai, Ana Abad, Bree Foley, Mark N Cruickshank, Jason Waithman
Acquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigens. Oncoimmunology 8 (8) (2019)
Shaokang Ma, Jonathan Chee, Vanessa S Fear, Catherine A Forbes, Louis Boon, Ian M Dick, Bruce W S Robinson, Jenette Creaney
Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome. Oncoimmunology 9 (1) (2019)
Jonathan Chee, Chelsea Wilson, Anthony Buzzai, Ben Wylie, Catherine A Forbes, Mitchell Booth, Nicola Principe, Bree Foley, Mark N Cruickshank, Jason Waithman
Impaired T cell proliferation by ex vivo BET-inhibition impedes adoptive immunotherapy in a murine melanoma model. Epigenetics 15 (1-2) (2019)
Prerak M Trivedi, Stacey Fynch, Lucy M Kennedy, Jonathan Chee, Balasubramanian Krishnamurthy, Lorraine A O'Reilly, Andreas Strasser, Thomas W H Kay, Helen E Thomas
Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice. Cell death discovery 5 (2019)
Vanessa S Fear, C A Forbes, Jonathan Chee, S Ma, S Neeve, L Celliers, Scott A Fisher, Ian M Dick, J Creaney, B W S Robinson
Neo-antigen specific T cell responses indicate the presence of metastases before imaging. Scientific reports 9 (1) (2019)
Jonathan Chee, Mark W Watson, Abha Chopra, Bella Nguyen, Alistair M Cook, Jenette Creaney, Willem J Lesterhuis, Bruce W Robinson, Y C Gary Lee, Anna K Nowak, Richard A Lake, Alison M McDonnell
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors. BMC research notes 11 (1) (2018)
Vanessa S Fear, Caitlin Tilsed, Jonathan Chee, Catherine A Forbes, Thomas Casey, Jessica N Solin, Sally M Lansley, William Joost Lesterhuis, Ian M Dick, Anna K Nowak, Bruce W Robinson, Richard A Lake, Scott A Fisher
Combination immune checkpoint blockade as an effective therapy for mesothelioma. Oncoimmunology 7 (10) (2018)

Jonathan Chee.css-eqlu8i{font-size:small;padding-left:4px;} (J Chee)

Publication Activity (10 Years)

Top Topics

Top Venues

Jonathan Chee (J Chee)